Navigation Links
DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
Date:9/18/2007

MISSISSAUGA, ON, Sept. 18 /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX: DAX) (Nasdaq: DRAX) will participate in the 2007 UBS Global Life Sciences Conference, which is being held in New York, NY, from September 24 - 27, 2007 at The Grand Hyatt Hotel. Mr. Dan Brazier, Chief Operating Officer, is scheduled to present on Monday September 24, at 1:00 p.m. ET.

Investors can listen to a live audio webcast of the DRAXIS presentation or can access the replay for 30 days following the conference at DRAXIS website at http://www.draxis.com

About DRAXIS Health Inc.:

DRAXIS Health, through its wholly owned operating subsidiary, DRAXIS Specialty Pharmaceuticals Inc., provides products in three categories: sterile products, non-sterile products and radiopharmaceuticals. Sterile products include liquid and freeze-dried (lyophilized) injectables plus sterile ointments and creams. Non-sterile products are produced as solid oral and semi-solid dosage forms. Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are provided through the DRAXIS Pharma division and radiopharmaceuticals are developed, produced, and sold through the DRAXIMAGE division. DRAXIS employs approximately 500 staff in its Montreal facility.

For additional information please visit http://www.draxis.com

Caution Concerning Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and as contemplated under other applicable securities legislation. These statements can be identified by the use of forward-looking terminology such as "may," "will," "expect," "anticipate," "estimate," "continue," "plan," "intend," "believe" or other similar words. These statements discuss future expectations concerning results of operations or financial condition or provide other forward-looking information. Our actual results, performance or achievements could be significantly different from the results expressed in, or implied by, those forward-looking statements. You should not place undue reliance on any forward-looking statement, which speaks only as of the date made.

These statements are not guarantees of future performance. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks, uncertainties and other factors that may cause the actual results or performance of the Company to be materially different from such statements or from any future results or performance implied thereby. Factors that could cause the Company's results or performance to differ materially from a conclusion, forecast or projection in the forward-looking statements include, but are not limited to:

- the achievement of desired clinical trial results related to the

Company's pipeline products;

- timely regulatory approval of the Company's products;

- the ability to comply with regulatory requirements applicable to the

manufacture and marketing of the Company's products;

- the Company's ability to obtain and enforce effective patents;

- the non-infringement of third party patents or proprietary rights by

the Company and its products;

- factors beyond our control that could cause interruptions in our

operations in our single manufacturing facility (including, without

limitation, material equipment breakdowns);

- reimbursement policies related to health care;

- the establishment and maintenance of strategic collaborative and

commercial relationships;

- the Company's dependence on a small number of key customers;

- the disclosure of confidential information by our collaborators,

employees or consultants;

- the preservation of healthy working relationships with the Company's

union and employees;

- the Company's ability to grow the business;

- the fluctuation of our financial results and exchange and interest

rate fluctuations;

- the adaptation to changing technologies;

- the loss of key personnel;

- the avoidance of product liability claims;

- the loss incurred if current lawsuits against us succeed;

- the volatility of the price of our common shares;

- market acceptance of the Company's products; and

- the risks described in "Item 3. Key Information - Risk Factors" in

the Annual Report Form 20-F filed by the Company with the United

States Securities and Exchange Commission and which is also filed as

the Company's Annual Information Form with Canadian securities

regulators.

For additional information with respect to certain of these and other factors, and relating to the Company generally, reference is made to the Company's most recent filings with the United States Securities and Exchange Commission (available on EDGAR at http://www.sec.gov) and the filings made by the Company with Canadian securities regulators (available on SEDAR at http://www.sedar.com). The forward-looking statements contained in this new release represent the Company's expectations as at September 17, 2007. Unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DRAXIS Health Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... ... ... total solar eclipse will occur across the U.S. on Monday, August 21, causing ... sun and Earth. This rare event will be magnificent to witness, but what does it ... the road during the total eclipse of the sun. , 1. Plan ahead. The eclipse’s ...
(Date:8/20/2017)... ... August 20, 2017 , ... ... HIPAA ComplyPAK™ Compliance Management System has assisted multiple clients in successfully passing ... Accountants, Service Organization Control Level 2 (AICPA SOC Level 2), and State Data ...
(Date:8/20/2017)... ... 20, 2017 , ... State Farm Neighborhood Assist® has named The Southern ... $25,000 grant. If the initiative wins, Gals Lead – Dream Queen Foundation’s signature teen ... area of St. Mary’s, Calvert and Charles Counties. The program could potentially impact nearly ...
(Date:8/20/2017)... CO (PRWEB) , ... August 20, 2017 , ... Are ... the same household? If so, you may be interested in participating in a ... purpose of this research is to understand more about the relational aspects of adults ...
(Date:8/19/2017)... ... August 19, 2017 , ... DMG Productions, producers of ... Group in an upcoming episode, slated to air fourth quarter 2017. Check your ... Aurum Group; a company committed to supporting dentistry using the most technologically advanced ...
Breaking Medicine News(10 mins):
(Date:8/18/2017)... Aug. 18, 2017  Nortis today announced the awarding of a $688K National ... the third year of a Small Business Innovation Research (SBIR)?Fast-track ... of Neurological Disorders and Stroke (NINDS).?  ... Nortis ParVivo Chip used ... ...
(Date:8/17/2017)... ANGELES , Aug. 17, 2017 MJAC2017 ... CBMJ – Canna Broadcast Media, today reveals its leading lineup. ... Isodiol International Inc., a global cannabis innovator specializing in the ... sponsor of the conference. MassRoots, Rambridge™ and The Green Organic ... Bay Inc. and Namaste Vapes™ as silver sponsors. ...
(Date:8/17/2017)... CAESAREA, Israel , August 17, 2017 /PRNewswire/ ... digital health Company with mobile health and big ... securities purchase agreements with domestic and non-U.S. investors ... common stock and shares of the Company,s newly ... private placement offerings. The Company expects to conduct ...
Breaking Medicine Technology: